<DOC>
	<DOCNO>NCT01468545</DOCNO>
	<brief_summary>Ventavis 's treatment pulmonary hypertension , administer inhaler call I-Neb . In patient , non compliance treatment become ineffective increase complication mortality disease . It therefore important know adherence patient treatment try promote . One possibility reach good level adherence patient education regard drug administration also comply well possible recommendation physician . For reason , objective study demonstrate improvement level treatment compliance follow strategy continue education , assess device software call Insight . The special procedure participate study patient involve could receive train usual . Investigators expect involve study around 50 patient treatment Ventavis diagnose Pulmonary Arterial Hypertension 10-12 hospital throughout Spain . The patient participate study follow 12 month inclusion study perform around 5 visit total .</brief_summary>
	<brief_title>Educational Training Influence Patients With PAH ( Pulmonary Artery Hypertension ) Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>Male female patient &gt; 18 year age . Patients New York Heart Association ( NYHA ) functional class IIIV pulmonary hypertension treat Ventavis least three month use neb ® AAD ® system . Patients accept participation study sign inform consent . Patients ability understand follow instruction able participate duration study . exclusion Criteria : Patients severe cognitive impairment . Geographically unstable patient follow 12 month study . Patients life expectancy least 12 month . Patients participate another study time inclusion . .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Education</keyword>
	<keyword>Ventavis</keyword>
	<keyword>Adherence</keyword>
	<keyword>PAH</keyword>
	<keyword>Pulmonary artery hypertension</keyword>
</DOC>